The FAAA has voiced concerns over the Labor government's proposed superannuation tax, saying if they are negotiating with the Greens, a reduction in the cap to $2 million would be problematic.

Importantly, the $190 billion superannuation fund has recruited Frank Bulman to lead its private equity team in Europe along ...

Former financial adviser Abdullah Popal has been charged with alleged fraud offences in Sydney's north-west, accused of hoodwinking five individuals out of over $160,000 from their self-managed super ...

Two of the country's biggest superannuation funds have used their voting power at the Woodside AGM, saying the gas producer has "fallen short" of shareholder expectations.

A collective of industry bodies, including Chartered Accountants ANZ and the Financial Advice Association Australia, want the government to push the implementation of Payday Super to July 2028.

In response to a discussion paper published by the Australian Securities and Investments Commission (ASIC) in February, the Australian Securities Exchange (ASX) has outlined several opportunities to ...

The Financial Advice Association of Australia (FAAA) has opposed collective charging for "always complex and costly" retirement planning advice and emphasised the need for consumer protection in the ...

A former Apostle Funds Management global distribution lead will head up APAC and Middle East for a London-based firm.

The new fund, VistaOne, will provide APAC investors with access to a balanced portfolio of 'mission-critical' software solutions via Vista's private equity platform.

An alarming number of licensees are spending less on compliance, a new survey from Holley Nethercote shows, but a slew of reforms slated within the next 18 months could catch them off guard.

ASIC is again taking action against Macquarie Bank for "multiple and significant compliance failures" relating to its futures-dealing business and over-the-counter (OTC) derivatives trade reporting.

HCF Life Insurance has been fined $750,000 by the Federal Court for misleading the public about a pre-existing condition term under its Recover products.